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Introduction
Hypertension- The Silent Killer
• Affects 85 million Americans, 
age 20 years and older (American 
Heart Association [AHA], 2017)
• There is no cure but proper 
health care management 
minimizes lifestyle impact
• Two different categories:
Primary Hypertension (also 
referred to as idiopathic or 
essential hypertension)
• Caused by genetic and/or 
environmental changes
Secondary Hypertension
• Caused by an underlying 
condition that may involve 
the renal, vascular, or 
endocrine systems 
(Alexander,2017)
Signs and Symptoms 
of Primary Hypertension
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Hypertension is known as the “silent killer” because an individual with the 
disease may experience no warning signs or symptoms; this results in 47% of 
those with hypertension not knowing they have the disease (Patel et al., 
p.1284, 2016). Of those patients who are aware of the diagnosis, only 35% are 
receiving pharmacologic treatment (Patel et al., p. 1284, 2016). This further 
indicates the need for improved education and community resources through 
primary care to prevent disease advancement and to reduce mortality. It is not 
until later stages of the disease that any dysfunctions to an individual’s normal 
state of health are noticed, which puts an individual at increased risk for end 
organ damage related to hypertension. 
The following guidelines are from the American Heart Association as of 2017 
on how to categorize blood pressure readings (American Heart Association, 
2017). 
Normal blood pressure requires SBP and DBP to meet parameters unlike the other 
four classifications where either the SBP or the DBP parameters must be met.
• Vomiting and headaches may be noticed by some individuals as a 
symptom that triggers the need for medical attention that may then lead 
to a diagnosis of primary hypertension (Centers for Disease Control and 
Prevention [CDC], 2017).
• During a hypertensive crisis additional signs and symptoms may be 
experienced (American Heart Association, 2017).
• Shortness of breath, anxiety, blurry vision, and seizures
It is the responsibility of the patient to have regular blood pressure monitoring 
to be able to identify changes in blood pressure values that warrant medical 
attention for potential primary hypertension diagnosis.
Baseline and successive lab work, physical 
assessment, and blood pressure monitoring will be 
needed. It is up to medical professionals to obtain 
accurate results and interpret them on an 
individual basis. To accurately diagnose primary 
hypertension, secondary hypertension must first 
be ruled out. Then a patient’s blood pressure must 
be taken two or three times on several different 
visits (Siu, 2015). For those with high blood 
pressure who are already being monitored, 
additional measurements outside of the healthcare 
facility and in a standing positon may be of value to 
their treatment regimen (Siu, 2015). 
The U.S. Preventative Services Task Force has 
made the following recommendations for 
screening and treatment (Siu, 2015):
✓Adults 40 years and older and those at risk 
should have annual screenings. At risk patients 
include those whose blood pressure is 130 to 
139/85 to 89 mm Hg, are overweight or obese, and 
are African American. 
✓Adults 18 to 39 years old with blood pressure of 
<130/85 mm Hg with no risk factors should be 
screened every three to five years.
✓ Initial treatment for nonblack patients should 
include a thiazide diuretic, a calcium-channel 
blocker, an angiotensin converting enzyme 
inhibitor, or an angiotensin-receptor blocker. 
✓ Initial treatment for black patients should 
include a thiazide or a calcium-channel blocker.
Although the underlying pathophysiological 
mechanism of primary hypertension is unclear, 
there are risk factors known to put a patient at 
increased risk for developing the disease. It is 
crucial to successful prevention and management 
of primary hypertension to educate on weight loss 
strategies, methods to reduce salt intake, exercise, 
and the negative impact of alcohol consumption 
and cigarette smoking (American Heart 
Association, 2017).
“Essential hypertension accounts 
for 90-95% of adult cases” 
according to Alexander (2017)  and 
is the focus of this poster.  With 
such high prevalence rates, the 
family nurse practitioner will be 
faced with evaluating this disease 
daily. It is crucial to have a thorough 
understanding of the 
pathophysiology of primary 
hypertension and guidelines for 
management, and to ensure the 
patient has a thorough 
understanding of the diagnosis.  
The significant amount of 
modifiable risk factors and multiple 
variations in treatment guidelines 
for hypertension make it a complex 
disease process for clinicians. 
Smoking, obesity, and a sedentary 
lifestyle are all aspects of a patient’s 
life that can be altered to reduce the 
risk of primary hypertension. This 
can be a challenging aspect of 
patient care as these risk factors are 
becoming more prevalent as 
evidenced by 30% of the adult 
population being obese (Rosendorff
et al., p. 1377, 2015). Primary care 
providers are in an especially 
unique position to not only 
diagnose and treat but also provide 
education about primary 
hypertension that will make a 
significant impact in reducing the 
negative effects of the disease to 
individual patients and society.
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Image 1.  Depicted above are several of the pathophysiologic factors that 
impact development of primary hypertension. 
Jenkins, P. G. (2004). Pathogenesis of hypertension. ANNALS OF INTERNAL MEDICINE, 141  
Retrieved from annals.org.
Implications for Nursing
Patients with the greatest health care 
complications often have a history of coronary 
artery disease, renal failure, and stroke, all of which 
are potential complications of primary 
hypertension (Rosendorff et al., p.1373, 2015). The 
underlying cause of many disease processes is 
multifactorial and the degree to which it impacts 
the patient often depends on additional co-
morbidities, and genetic and environmental factors. 
Without a clear understanding of how primary 
hypertension is developed it is imperative that 
health care providers and patients work together to 
decrease risk through life style modification and 
individualized treatment regimens. Primary health 
care providers can make an enormous impact to 
patient mortality and health care expenses with 
proper understanding of the pathophysiologic 
process that is occurring and causing dysfunction in 
the patient’s health.
Conclusion
These pathophysiology processes occur 
over a significant period with minimal signs 
and symptoms therefore causing significant 
end organ. With proper health care and 
treatment, end organ damage can be limited 
or avoided. 
• Abnormal stimulation of the sympathetic 
nervous system as seen with primary 
hypertension is a predictor of 
cardiovascular morbidity and mortality 
due to blood pressure variability and 
excess norepinephrine release (Mancia & 
Grassi, p.1809, 2014). 
• The single diagnosis of primary 
hypertension puts an individual at risk 
for coronary artery disease, stroke, and 
renal failure (Rosendorff et al., p. 1373, 
2015). The sustained high pressure in 
systemic blood vessels and vascular 
remodeling as previously discussed 
ultimately causes these organs to fail.
• Renal function is impaired with sustained 
high blood pressure and 1 in 5 adults 
diagnosed with hypertension will develop 
chronic kidney disease (CDC, 2017).
• It is important to know that 47% of 
adults have their hypertension controlled, 
meaning their SBP is less than 140 and 
DBP is less than 90 (Scordo & Pickett, 
p.28, 2015). 
• Guidelines published by the Joint 
National Committee, American Heart 
Association, and American College of 
Cardiology have differing treatment 
guidelines, therefore clinical evaluation of 
co-morbidities and risk factors must be 
considered in the plan of care as patients 
with coronary artery disease and renal 
failure may follow differing regimens 
(Scordo & Pickett, pp.28 & 32, 2015).
Despite years of research and many different theories, the pathophysiologic process that 
contributes to the development of primary hypertension is unclear. Several physiologic 
processes in combination with a genetic and environmental component are the basis for 
research and understanding this disease that is overwhelmingly seen in the population 
(Gonzalez, Valls, Brito, & Rodrigo, pp. 353-354, 2014). With each heart beat a systolic and 
diastolic pressure are created within the blood vessels resulting in the blood pressure.  There 
is an increase in blood pressure when the heart has to increase the force in which it pumps 
blood out of the heart (American Heart Association, 2017). This pattern of increased 
pressure over time is what leads to hypertension but the mechanism for which this output 
and resistance increase is not entirely understood. Most recently the pathophysiologic 
changes involving endothelial dysfunction and oxidative stress, the effects of the autonomic 
nervous system, and the renin-angiotensin activation system have been the focus of research 
(Gonzalez et al., pp.353-355, 2014). 
• The autonomic nervous system greatly influences homeostasis of the cardiovascular 
system and studies have shown that sympathetic hyperactivity especially related to 
adrenergic activation can be influential in primary hypertension (Mancia & Grassi, 
pp.1806&1812, 2014). Excessive response to environmental stimuli, and a decrease in 
arterial baroreceptors responsiveness to changes in blood pressure are two thoughts that 
help explain what causes the sympathetic overdrive (Mancia & Grassi, p. 1810, 2014). 
Studies have shown that adrenergic neurotransmitters (norepinephrine and epinephrine) 
are released at higher amounts in those with primary hypertension and the activation 
continues to rise with an increase in blood pressure (Mancia & Grassi, pp.1804-1805, 2014).
• The renin-angiotensin aldosterone system (RAAS) is a well understood component to 
maintaining a normal blood pressure through regulating blood volume and systemic 
vascular resistance. Renin is an important enzyme released from the kidneys in response to 
changes in blood pressure and blood flow through the kidneys (Klabunde, 2016). This 
release then triggers the cascade of events of RAAS. Angiotensin II has several important 
functions including vasoconstriction, contributing to endothelial dysfunction, stimulating 
vasopressin release, and triggering the release of aldosterone (Klabunde, 2016). Aldosterone 
is a mineralcorticoid that regulates the kidneys to increase sodium and fluid retention 
(Klabunde, 2016). This system normally gives feedback to the kidneys to then decrease renin 
secretion but in patients with hypertension there is an abnormal or increased amount of 
renin released which intensifies the effects of the system as mentioned above (Gonzalez et al., 
p.355, 2014). 
• Oxidative stress can contribute to endothelial dysfunction and occurs when there is an 
increased amount of reactive oxygen species (ROS) without sufficient antioxidant defense 
systems (Gonzalez et al., pp.353-354, 2014) as image 2 shows. Reactive oxygen species are 
released in the blood vessels by many enzymatic sources, primarily the biochemical source 
NOX which when released has a primary role in renal dysfunction and vascular damage. 
Vasoconstriction is another effect of reactive oxygen species that may alter the homeostasis 
of the vascular wall therefore inducing hypertension (Gonzalez et al., p.354 2014).
The Underlying Pathophysiology
Endothelial cells line the 
blood vessel walls and 
dysfunctions to the vessel 
walls such as inflammation, 
reduced vasodilation, and 
increased thrombus may occur 
and contribute to primary 
hypertension (Gonzalez et al., 
p. 354, 2014). For example, in 
a patient with hypertension 
there is increased release of 
angiotensin II a 
vasoconstrictor and decreased 
release of nitric oxide a potent 
vasodilator (Rosendorff et al., 
p. 1379, 2015).
Systolic Blood Pressure
(SBP)
Diastolic Blood Pressure 
(DBP)
Normal Blood Pressure <120 <80
Prehypertension 120-139 80-89
Hypertension Stage I 140-159 90-99
Hypertension Stage II 160 or higher 100 or higher
Hypertensive Crisis > 180 >110
The inflammatory response of the 
immune system contributes to 
the pathogenesis of hypertension 
when actions of cytokines and 
chemokines are misdirected in 
the kidneys and vasculature. 
Studies have shown that patients 
with hypertension have increased 
levels of the chemokine CCL2 and 
its receptor CCR2 on circulating 
monocytes. The amplified binding 
of CCL2 to its receptors has 
detrimental effects of infiltrating 
tissues and causing further tissue 
inflammation and injury 
(Rudemiller & Crowley, pp.404-
405,  2017). 
Vascular remodeling can 
occur as a result of local 
vessel inflammation or an 
increase in release of 
angiotensin II that results 
in changes to cell growth, 
migration, and death. 
These changes alter vessel 
lumen size which increases 
vessel resistance and in 
turn increase the blood 
pressure (Renna, Heras, & 
Miatello, pp.1-2, 2013).   
All three concepts impact endothelial 
dysfunction which is a contributor to 
primary hypertension
Image 2. How reactive oxygen species (ROS) 
impact hypertension
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